These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 12503245)

  • 1. [Analgesic effect of kynurenic acid].
    Kékesi G; Horváth G
    Ideggyogy Sz; 2002 Sep; 55(9-10):313-22. PubMed ID: 12503245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The peripheral antinociceptive effects of endomorphin-1 and kynurenic acid in the rat inflamed joint model.
    Mecs L; Tuboly G; Nagy E; Benedek G; Horvath G
    Anesth Analg; 2009 Oct; 109(4):1297-304. PubMed ID: 19762760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The inimitable kynurenic acid: the roles of different ionotropic receptors in the action of kynurenic acid at a spinal level.
    Tuboly G; Tar L; Bohar Z; Safrany-Fark A; Petrovszki Z; Kekesi G; Vecsei L; Pardutz A; Horvath G
    Brain Res Bull; 2015 Mar; 112():52-60. PubMed ID: 25677204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antinociceptive interactions of triple and quadruple combinations of endogenous ligands at the spinal level.
    Horvath G; Kekesi G; Tuboly G; Benedek G
    Brain Res; 2007 Jun; 1155():42-8. PubMed ID: 17482581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-independent antinociceptive interaction of endogenous ligands at the spinal level.
    Kekesi G; Joo G; Csullog E; Peter-Szabo M; Benedek G; Horvath G
    Brain Res; 2004 Dec; 1029(1):93-102. PubMed ID: 15533320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to kynurenic acid of the NMDA receptor-dependent toxicity of 3-nitropropionic acid and cyanide in cerebellar granule neurons.
    Fatokun AA; Smith RA; Stone TW
    Brain Res; 2008 Jun; 1215():200-7. PubMed ID: 18486115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein coupled receptor 35 (GPR35) activation and inflammatory pain: Studies on the antinociceptive effects of kynurenic acid and zaprinast.
    Cosi C; Mannaioni G; Cozzi A; Carlà V; Sili M; Cavone L; Maratea D; Moroni F
    Neuropharmacology; 2011 Jun; 60(7-8):1227-31. PubMed ID: 21110987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancement of morphine antinociception with the peptide N-methyl-D-aspartate receptor antagonist [Ser1]-histogranin in the rat formalin test.
    Hama A; Basler A; Sagen J
    Brain Res; 2006 Jun; 1095(1):59-64. PubMed ID: 16712813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antinociceptive properties of the hydroalcoholic extract and the flavonoid rutin obtained from Polygala paniculata L. in mice.
    Lapa Fda R; Gadotti VM; Missau FC; Pizzolatti MG; Marques MC; Dafré AL; Farina M; Rodrigues AL; Santos AR
    Basic Clin Pharmacol Toxicol; 2009 Apr; 104(4):306-15. PubMed ID: 19281602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of supraspinal NMDA receptors by both D-serine alone or in combination with morphine leads to the potentiation of antinociception in tail-flick test of rats.
    Yoshikawa M; Ito K; Maeda M; Akahori K; Takahashi S; Jin XL; Matsuda M; Suzuki T; Oka T; Kobayashi H; Hashimoto A
    Eur J Pharmacol; 2007 Jun; 565(1-3):89-97. PubMed ID: 17383634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemically administered glucosamine-kynurenic acid, but not pure kynurenic acid, is effective in decreasing the evoked activity in area CA1 of the rat hippocampus.
    Robotka H; Németh H; Somlai C; Vécsei L; Toldi J
    Eur J Pharmacol; 2005 Apr; 513(1-2):75-80. PubMed ID: 15878711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
    Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
    Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kynurenic acid amides as novel NR2B selective NMDA receptor antagonists.
    Borza I; Kolok S; Galgóczy K; Gere A; Horváth C; Farkas S; Greiner I; Domány G
    Bioorg Med Chem Lett; 2007 Jan; 17(2):406-9. PubMed ID: 17074483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive effect and interaction of uncompetitive and competitive NMDA receptor antagonists upon capsaicin and paw pressure testing in normal and monoarthritic rats.
    Pelissier T; Infante C; Constandil L; Espinosa J; Lapeyra CD; Hernández A
    Pain; 2008 Jan; 134(1-2):113-27. PubMed ID: 17517475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ketamine enhances the efficacy to and delays the development of tolerance to electroacupuncture-induced antinociception in rats.
    Huang C; Long H; Shi YS; Han JS; Wan Y
    Neurosci Lett; 2005 Feb; 375(2):138-42. PubMed ID: 15670657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
    Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
    Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midazolam attenuates the antinociception induced by d-serine or morphine at the supraspinal level in rats.
    Ito K; Yoshikawa M; Maeda M; Jin XL; Takahashi S; Matsuda M; Tamaki R; Kobayashi H; Suzuki T; Hashimoto A
    Eur J Pharmacol; 2008 May; 586(1-3):139-44. PubMed ID: 18384770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
    Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
    Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.